Trial intelligence / Profile preview

Metformin for insulin action and secretion in women with prior gestational diabetes

2005-000899-40Phase 3Completed

Sponsor
Laboratori Guidotti
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of metformin in impaired fasting glucose (IFG) and prediabetes, sponsored by Laboratori Guidotti. Primary endpoint: Whole body insulin sensitivity index (ISI-Matsuda). Started Aug 2006; status: completed.

02

Drugs

metformin
03

Conditions

impaired fasting glucose (IFG)prediabetes

Beyond the preview

Go deeper on 2005-000899-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000899-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call